Genomics researchers advance Queensland health care

Published Wednesday, 26 April, 2017 at 01:45 PM

Minister for Health and Minister for Ambulance Services
The Honourable Cameron Dick

The Palaszczuk Government is positioning Queensland as a world leader in the translation of genomics research into healthcare practice, today announcing the first recipients of its $25 million Queensland Genomics Health Alliance (QGHA) funding.

Speaking at CEDA, Health and Ambulance Services Minister Cameron Dick announced $4.8 million had been awarded to recipients of the first of three rounds.

“Four of the projects will receive $600,000 over 18 months to demonstrate the use of genomic medicine to diagnose and manage patients with melanoma, lung cancer, infectious diseases and maturity-onset diabetes of the young,” Mr Dick said.

“The researchers and clinicians intend to show how genomics can provide significant benefits to the diagnosis and management of people suffering from these conditions.

“Five projects aimed at building the capability of Queensland’s health services to implement genomics to improve the health of Queenslanders will receive $480,000 over 18 months.

“They will establish infrastructure and capacity in information management, genomic testing innovation, workforce development, ethics, legal and social implications and evaluation of the application of clinical genomics in the Queensland health system.”

He said one example of how important these projects were to Queenslanders’ future was the workforce development project.

“It is aimed at building genomics knowledge and skills in current and future clinicians by developing teaching materials to upskill scientists and clinicians in genomics, including establishing the first postgraduate program in Diagnostic Genomics in Australasia,” Mr Dick said.

“This funding is part of the Palaszczuk Government’s five year commitment to QGHA, which is a collaboration involving Queensland-based universities and research organisations, the Queensland Hospital and Health Services network, private health providers, and associated health organisations throughout Queensland.”

Executive Director of QGHA David Bunker said the funding had been allocated to this ground-breaking initiative to fast track genomics research and its translation into our healthcare system.

“The capacity for genomics to improve patient outcomes is a reality, and it’s important that decisions around health systems are made based on research evidence,” Mr Bunker said.

Visit for more information about the Queensland Genomics Health Alliance.

The successful four clinical demonstration projects receiving $600,000 each over 18 months are:

Project Title

Chief Investigator and Primary Affiliation

A genomics approach for screening of patients at high risk of melanoma

Peter Soyer (UQ)

Evaluation of Clinical, Ethical and Economic Factors in Targeted Genetic Testing for Maturity-Onset Diabetes of the Young in Gestational Diabetes

John Prins (Mater Research)

Whole Genome Sequencing to Track, Treat and Prevent Nosocomial Infections

David Paterson (UQ)

Bring Modern Genomics to the Management of Lung Cancer in Queensland

Matthew Brown (QUT)



The successful five capability-building workstream projects receiving $480,000 each over 18 months are:

Project Title

Chief Investigator/s and Primary Affiliation

Implementation of Genomics into Queensland Healthcare: ethical, legal and social implications and policy challenges

John Devereux (UQ);

Belinda Bennett (QUT);

Nic Waddell (QIMR Berghofer)

Establishment of MSc in Diagnostic Genomics at Queensland University of Technology and Development of Continuing Education Material for Workforce Development

Lyn Griffiths (QUT)

Evaluation of Clinical Genomics Projects in Action in Queensland

Louisa Gordon (QIMR Berghofer)

Integrating Next-Generation Genomic Platforms into Routine Clinical Practice

Sunil Lakhani (Pathology Qld)

Towards a Queensland Genomic Information management Architecture

David Hansen (CSIRO)

John Pearson (QIMR Berghofer)



Media contact:

Emma McBryde        0447 155 332